Photocure launches Cysview Commercial Operations in Canada
Press release – Oslo, Norway, 3 January 2022: Photocure ASA (Photocure, PHO: OSE) today announces the start of its Cysview[®] sales, marketing and distribution operations in the Canadian market. In August 2021 Photocure had reached an agreement with BioSyent Pharma Inc. (“BioSyent”) to reacquire the marketing and distribution rights to Cysview[ ]in Canada, effective on January 1[st], 2022.The reacquisition of marketing and distribution rights enables Photocure’s direct management of the Cysview brand in Canada and consolidates the territory into Photocure’s existing U.S. business to form